SARAH TOMASHEFSKI: Open Payments
NPI 1396271870 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,874 in 66 payments from 15 companies in 2025. Trend: 2023 $953 · 2024 $3,160 · 2025 $16,874
Consulting: $11,830Food & beverage: $2,863Travel & lodging: $2,164Education: $17
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 25 | $11,624 |
| GlaxoSmithKline, LLC. | 6 | $3,321 |
| Insmed, Inc. | 4 | $487 |
| United Therapeutics Corporation | 10 | $431 |
| AstraZeneca Pharmaceuticals LP | 6 | $326 |
| Regeneron Healthcare Solutions, Inc. | 1 | $128 |
| Grifols Shared Services North America, Inc. | 1 | $118 |
| Abbott Laboratories | 1 | $113 |
| Grifols USA, LLC | 2 | $109 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $68 |
Products named: DUPIXENT, Prolastin-C Liquid, STEEN SOLUTION, CARDIOMEMS, BREZTRI, FASENRA, TRELEGY ELLIPTA, JASCAYD.
Industry payments across SC — which companies pay providers there.
